Tolvaptan (Samsca) - Important Safety Information from Otsuka as approved by the Irish Medicines Board
03 April 2012
Important Safety Information communication from Otsuka on the risks of increases in serum sodium which are too rapid when using Tolvaptan (Samsca) and how to minimise the risks.
Important Safety Information - Tolvaptan (Samsca)